ReviewJournal of inflammation research2025
The Dual Role of Nitric Oxide in Allergic Rhinitis: From the NO/cGMP Signaling Pathway to Possible New Therapeutic Targets for Organelle Damage.
Review in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Allergic rhinitis (AR) is a chronic, non-infectious condition mediated by IgE that primarily affects the nasal mucosa. Recent studies have indicated a relationship between nitric oxide (NO) and the pathogenesis of allergic rhinitis. This review integrates the NO/cGMP pathway with mitochondrial, endoplasmic reticulum, and lysosomal pathways, as well as related translational targets, aiming to systematically dissect the associations between these pathways and their roles in AR. By synthesizing literature from the PubMed database (1994-2024), we conducted an in-depth analysis of the specific mechanisms by which homeostatic NO and pathological NO contribute to the pathogenesis of AR. Additionally, we investigate the impact of the NO derivative peroxynitrite on mitochondrial, endoplasmic reticulum, and lysosomal organelles. Based on these findings, we further explore potential treatment modalities for AR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.